Medium-level self-managers had relatively medium levels of self-efficacy, self-management abilities of depressive symptoms, and eHealth literacy. Medium-level self-managers felt burdened by using ...

Kim Kardashian has disclosed that a small aneurysm has been detected in her brain. The 45-year-old reality television star and actress, in her show The Kardashians, opened up on the brain condition, ...

11:20, Fri, Oct 24, 2025 Updated: 11:20, Fri, Oct 24, 2025 Kim Kardashian has revealed that she has a "little" brain aneurysm, as seen in a preview clip of the latest season of The Kardashians. In the ...

Actress Isabelle Adora Tate battled a rare neurological disorder before her death at 23. The 9-1-1 Nashville star, who passed away on Sunday, suffered from a rare form of Charcot-Marie-Tooth disease, ...

Health officials have issued a "stay at home" warning to anyone with symptoms of norovirus to help limit the spread of the highly contagious virus. It comes as cases of the winter vomiting bug are on ...

Regeneron has given up on a CAR-T candidate acquired from 2seventy bio last year, before it entered the second part of a phase 1/2 lymphoma study. The dual-targeting CAR-T, dubbed bbT369, was being ...

Persistent night sweats, often dismissed, can be a subtle warning sign for serious health issues, including various cancers. While not always indicative of malignancy, these excessive nighttime ...

The HSE has urged the public to follow isolation guidelines as the number of confirmed Covid cases continues to tick upwards. The latest data from the Health Protection Surveillance Centre (HPSC) ...

Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have defined a path forward for roluperidone's clinical ...

10:23, Tue, Oct 21, 2025 Updated: 10:41, Tue, Oct 21, 2025 A doctor has described the six Covid symptoms he is seeing in patients as the virus circulates at medium levels in the UK. The latest wave of ...

Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have defined a path forward for roluperidone’s clinical ...